Carlos Alcaraz Skips Canadian Open, Threatening US Open Hopes

**Carlos Alcaraz** confirmed on 10 July 2026 that he will not appear in the Canadian Open, a key warm‑up for the US Open, after a lingering wrist injury forced him out of the Barcelona Open, Roland Garros and the grass‑court swing.

The Spanish prodigy first pulled out of the Barcelona Open in early April, citing a wrist problem that later proved severe enough to skip Roland Garros. In an Instagram post dated 4 April, Alcaraz wrote that medical tests advised caution and that he would sit out Rome and Paris while doctors monitored his progress. The same injury kept him off the HSBC Championships and Wimbledon, leaving fans without his trademark power game on grass.

Missing Toronto means Alcaraz loses a vital hard‑court rehearsal before the final Grand Slam of the year. The US Open starts on 31 August, giving him roughly eight weeks to recover. However, the lack of match play could hinder his timing and confidence. If he also skips the Cincinnati Masters, a top‑level event that usually sharpens his form, analysts will view his US Open participation as doubtful.

Alcaraz has posted short videos of light training on practice courts, but no competitive match footage has emerged. His team has not entered him for any ATP events after the Canadian Open, suggesting they are still evaluating his condition. The next possible checkpoint will be the US Open entry deadline on 15 August. Should his wrist show measurable improvement in the coming weeks, a wildcard or protected ranking could still see him in New York.

Alcaraz sits atop the rankings with 8,450 points after winning Wimbledon in July. Missing two major tournaments could see him drop several spots if rivals like Novak Djokovic or Daniil Medvedev capitalize on his absence. The ATP points he would have earned in Toronto (500) and Cincinnati (1000) are now up for grabs, potentially reshaping the year‑end top‑5.

Spanish fans expressed disappointment on social media, with many urging patience and a swift recovery. Sponsors such as Nike and Babolat released statements emphasizing their support for Alcaraz’s health over short‑term results. The consensus is clear: a healthy Alcaraz returning for the US Open would be a massive boost for viewership and ticket sales.

The next public update is expected after his scheduled medical review on 22 July. If the doctors give a green light, Alcaraz could aim for a late‑season comeback at the US Open, perhaps entering as a seeded player if his ranking holds. Otherwise, he may need to sit out the remainder of the season, focusing on a full recovery for the 2027 campaign.

*All information is drawn from The Spun’s report dated 10 July 2026.*